Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare the antiviral efficacy (sustained virologic response; SVR) of 48 weeks of GS-9190 versus placebo when administered in combination with 48 weeks of peginterferon alfa 2a (PEG) and ribavirin (RIBA)
Inclusion criteria
- Chronic hepatitis C virus infection